Steward Partners Investment Advisory’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Steward Partners Investment Advisory’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-14	Closed	–	–	2778
2019 Q3	$0	Hold	14	–	–	﹤0.01%	2798
2019 Q2	$1K	Buy	+14	New	+$1.7K	﹤0.01%	2570
2018 Q4	–	Sell	-13	Closed	-$3K	–	2293
2018 Q3	$3K	Sell	13 -25	-66%	-$5.92K	﹤0.01%	2311
2018 Q2	$9K	Hold	38	–	–	﹤0.01%	1793
2018 Q1	$9K	Sell	38 -4	-10%	-$1.05K	﹤0.01%	1621
2017 Q4	$13K	Buy	+42	New	+$13.8K	﹤0.01%	1284

Other funds holding DMK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LFAS

Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Steward Partners Investment Advisory's DMK Position: Q4 2019 in Review

Steward Partners Investment Advisory sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q4 2019, closing a stake of 14 shares.

Steward Partners Investment Advisory first reported a position in DMK in Q4 2017 and held it in 6 quarters. The position peaked at $13K in Q4 2017. 38 funds tracked by Wall St. Rank hold DMK as of Q4 2019.

Steward Partners Investment Advisory reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q4 2019 after selling out during the quarter.
Steward Partners Investment Advisory sold 14 DMK Pharmaceuticals Corporation Common Stock shares in Q4 2019.
Steward Partners Investment Advisory first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2017 and held it in 6 quarters.
Steward Partners Investment Advisory's DMK Pharmaceuticals Corporation Common Stock position peaked at $13K in Q4 2017.
38 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q4 2019.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2019, filed 17 Jan 2020.